187 related articles for article (PubMed ID: 28570576)
1. Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women.
Iyer SS; Sabula MJ; Mehta CC; Haddad LB; Brown NL; Amara RR; Ofotokun I; Sheth AN
PLoS One; 2017; 12(6):e0178193. PubMed ID: 28570576
[TBL] [Abstract][Full Text] [Related]
2. Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential.
Swaims-Kohlmeier A; Haaland RE; Haddad LB; Sheth AN; Evans-Strickfaden T; Lupo LD; Cordes S; Aguirre AJ; Lupoli KA; Chen CY; Ofotukun I; Hart CE; Kohlmeier JE
J Immunol; 2016 Jul; 197(1):368-76. PubMed ID: 27233960
[TBL] [Abstract][Full Text] [Related]
3. Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.
Lajoie J; Birse K; Mwangi L; Chen Y; Cheruiyot J; Akolo M; Mungai J; Boily-Larouche G; Romas L; Mutch S; Kimani M; Oyugi J; Ho EA; Burgener A; Kimani J; Fowke KR
J Int AIDS Soc; 2018 Jul; 21(7):e25150. PubMed ID: 30047573
[TBL] [Abstract][Full Text] [Related]
4. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
Munusamy Ponnan S; Thiruvengadam K; Tellapragada C; Ambikan AT; Narayanan A; Kathirvel S; Mathayan M; Shankar J; Rajaraman A; Afshan Amanulla M; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Velu V; Shacklett B; Neogi U; Hanna LE
Microbiol Spectr; 2021 Oct; 9(2):e0047021. PubMed ID: 34704803
[TBL] [Abstract][Full Text] [Related]
6. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract.
Kleppa E; Ramsuran V; Zulu S; Karlsen GH; Bere A; Passmore JA; Ndhlovu P; Lillebø K; Holmen SD; Onsrud M; Gundersen SG; Taylor M; Kjetland EF; Ndung'u T
PLoS One; 2014; 9(6):e98593. PubMed ID: 24896815
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility.
McKinnon LR; Nyanga B; Chege D; Izulla P; Kimani M; Huibner S; Gelmon L; Block KE; Cicala C; Anzala AO; Arthos J; Kimani J; Kaul R
J Immunol; 2011 Dec; 187(11):6032-42. PubMed ID: 22048765
[TBL] [Abstract][Full Text] [Related]
8. Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study.
McKinnon LR; Hughes SM; De Rosa SC; Martinson JA; Plants J; Brady KE; Gumbi PP; Adams DJ; Vojtech L; Galloway CG; Fialkow M; Lentz G; Gao D; Shu Z; Nyanga B; Izulla P; Kimani J; Kimwaki S; Bere A; Moodie Z; Landay AL; Passmore JA; Kaul R; Novak RM; McElrath MJ; Hladik F
PLoS One; 2014; 9(1):e85675. PubMed ID: 24454917
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women.
Joag V; Sivro A; Yende-Zuma N; Imam H; Samsunder N; Abdool Karim Q; Abdool Karim S; McKinnon L; Kaul R
PLoS One; 2018; 13(7):e0200359. PubMed ID: 29985942
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
Cohen CR; Moscicki AB; Scott ME; Ma Y; Shiboski S; Bukusi E; Daud I; Rebbapragada A; Brown J; Kaul R
AIDS; 2010 Aug; 24(13):2069-74. PubMed ID: 20588163
[TBL] [Abstract][Full Text] [Related]
11. Resident CD4+ alpha beta T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli.
Ibraghimov AR; Sacco RE; Sandor M; Iakoubov LZ; Lynch RG
Int Immunol; 1995 Nov; 7(11):1763-9. PubMed ID: 8580074
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract.
Jewanraj J; Ngcapu S; Osman F; Mtshali A; Singh R; Mansoor LE; Abdool Karim SS; Abdool Karim Q; Passmore JS; Liebenberg LJP
Front Reprod Health; 2020; 2():566559. PubMed ID: 36304709
[No Abstract] [Full Text] [Related]
13. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
14. Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV-infected women.
Shanmugasundaram U; Critchfield JW; Giudice LC; Smith-McCune K; Greenblatt RM; Shacklett BL
Am J Reprod Immunol; 2020 Jul; 84(1):e13246. PubMed ID: 32301548
[TBL] [Abstract][Full Text] [Related]
15. Identification of preferential CD4+ T-cell targets for HIV infection in the cervix.
Joag VR; McKinnon LR; Liu J; Kidane ST; Yudin MH; Nyanga B; Kimwaki S; Besel KE; Obila JO; Huibner S; Oyugi JO; Arthos J; Anzala O; Kimani J; Ostrowski MA; ; Kaul R
Mucosal Immunol; 2016 Jan; 9(1):1-12. PubMed ID: 25872482
[TBL] [Abstract][Full Text] [Related]
16. Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders.
Rahman S; Rabbani R; Wachihi C; Kimani J; Plummer FA; Ball TB; Burgener A
Am J Reprod Immunol; 2013 Jan; 69(1):64-72. PubMed ID: 22971020
[TBL] [Abstract][Full Text] [Related]
17. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
18. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.
Keller MJ; McGinn AP; Lo Y; Huber A; Espinoza L; Minkoff H; Colie C; Nowicki MJ; D'Souza G; Anastos K
Am J Reprod Immunol; 2016 Jun; 75(6):631-42. PubMed ID: 27145926
[TBL] [Abstract][Full Text] [Related]
20. Changes in genital tract immune cell populations after initiation of intrauterine contraception.
Achilles SL; Creinin MD; Stoner KA; Chen BA; Meyn L; Hillier SL
Am J Obstet Gynecol; 2014 Nov; 211(5):489.e1-9. PubMed ID: 24834865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
